4
Changes in Ownership
ImmunityBio, Inc. Filed Acc 0001529371-26-000008
Director sold 131,210 shares at $9.50 ($1,246,941)
- Director acquired 55,979 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Cohen Cheryl · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-02 | Exercise or conversion : show line 1 in the form 10b5-1 | +55,979 | $2.98 | $166,817 | 256,596 | D |
| 2026-07-02 | Sale : show line 2 in the form 10b5-1 | −131,210 | $9.50 | $1,246,941 | 125,386 | D |
| Open-market sales · 131,210 sh · avg $9.50 · $1,246,941 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-02 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | −55,979 | 111,958 | D |
Loading xslF345X06/wk-form4_1783383979.xml…